Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_assertion type Assertion NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_head.
- NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_assertion wasGeneratedBy ECO_0000203 NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_provenance.
- NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_assertion wasDerivedFrom befree-2016 NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_provenance.
- NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_assertion SIO_000772 16508981 NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_provenance.
- NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_assertion evidence source_evidence_literature NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_provenance.
- NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_assertion description "[When KIRs were analyzed in combination with their HLA ligands, the proportion of individuals carrying inhibitory KIR3DL1 and HLA-Bw4 but not activating receptor KIR3DS1, a combination presumed to be the most inhibitory of all KIR3DS1/3DL1/HLA-B combinations, was significantly increased in the MPA group compared with the control group (46.5% versus 27.0%; P = 0.014, OR 2.35, 95% CI 1.18-4.70).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538154.RA361FaxByH0BLImKM1Aosb5HRx7ll73eOtwv7pftcWi8130_provenance.